Aprea Therapeutics (APRE) Stock Chart & Stock Price History $3.35 +0.05 (+1.52%) (As of 11/14/2024 ET) Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Aprea Therapeutics Stock Price Performance5 Day Performance-5.63%1 Month Performance+8.77%3 Month Performance-1.76%6 Month Performance-42.24%Year-To-Date Performance-28.72%1 Year Performance-15.40% Receive APRE Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Aprea Therapeutics and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Behind the Markets📉 Warning: Market Crash Predicted - Secure Your SavingsThe last time the "Buffett Indicator" flashed this red was in 2000 - right before the market crashed 50%.Take these 4 steps to protect your retirement here >>> APRE Stock Chart for Friday, November, 15, 2024 APRE Chart by TradingView Aprea Therapeutics Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization11/14/2024$3.30$3.35+1.52%$3.42$3.1811,039 shs$18.19 million11/13/2024$3.43$3.30-3.79%$3.35$3.282,607 shs$17.92 million11/12/2024$3.52$3.43-2.56%$3.54$3.2214,709 shs$18.63 million11/11/2024$3.55$3.52-0.85%$3.77$3.156,827 shs$19.11 million11/08/2024$3.98$3.55-10.80%$4.00$3.2057,124 shs$19.28 million11/07/2024$3.99$3.98-0.25%$4.15$3.913,446 shs$21.62 million Get the Latest News and Ratings for APRE and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Aprea Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 11/06/2024$3.86$3.99+3.37%$4.08$3.8713,004 shs$21.67 million11/05/2024$3.97$3.86-2.77%$4.08$3.859,169 shs$20.96 million11/04/2024$3.92$3.97+1.28%$4.03$3.841,867 shs$21.56 million11/01/2024$3.91$3.92+0.26%$4.15$3.8621,184 shs$21.29 million10/31/2024$4.01$3.91-2.49%$4.17$3.8214,201 shs$21.24 million10/30/2024$4.24$4.01-5.42%$4.42$3.9213,578 shs$21.78 million10/29/2024$4.28$4.24-0.93%$4.30$4.039,038 shs$23.02 million10/28/2024$4.08$4.28+4.90%$4.28$3.9925,602 shs$23.24 million10/25/2024$3.90$4.08+4.62%$4.15$4.057,217 shs$22.15 million10/24/2024$3.90$3.90$4.20$3.8719,437 shs$21.18 million10/23/2024$4.18$3.90-6.70%$4.18$3.8619,545 shs$21.18 million10/22/2024$4.30$4.18-2.79%$4.35$4.0217,070 shs$22.70 million10/21/2024$4.40$4.30-2.27%$4.54$4.2722,897 shs$23.35 million10/18/2024$4.45$4.40-1.12%$5.01$4.1586,907 shs$23.89 million10/17/2024$3.50$4.45+27.14%$4.45$3.60146,897 shs$24.16 million10/16/2024$3.08$3.50+13.64%$4.39$3.21145,438 shs$19.01 million10/15/2024$2.56$3.08+20.31%$3.20$2.5755,025 shs$16.72 million10/14/2024$2.60$2.56-1.54%$2.62$2.5111,470 shs$13.90 million10/11/2024$2.54$2.60+2.36%$2.77$2.1539,497 shs$14.12 million10/10/2024$2.56$2.54-0.78%$2.66$2.495,856 shs$13.79 million10/09/2024$2.60$2.56-1.58%$2.61$2.1515,261 shs$13.90 million10/08/2024$2.62$2.60-0.73%$2.62$2.561,681 shs$14.12 million10/07/2024$2.60$2.62+0.77%$2.65$2.31255,936 shs$14.23 million10/04/2024$2.62$2.60-0.76%$2.69$2.6013,903 shs$14.12 million10/03/2024$2.61$2.62+0.38%$2.69$2.5512,096 shs$14.23 million10/02/2024$2.60$2.61+0.38%$2.71$2.5914,603 shs$14.17 million10/01/2024$2.75$2.60-5.45%$2.80$2.5432,566 shs$14.12 million09/30/2024$2.75$2.75$2.85$2.6015,783 shs$14.93 million09/27/2024$2.92$2.75-5.82%$2.95$2.739,365 shs$14.93 million09/26/2024$2.87$2.92+1.74%$2.95$2.802,549 shs$15.86 million09/25/2024$2.98$2.87-3.69%$3.00$2.2540,021 shs$15.58 million09/24/2024$3.06$2.98-2.61%$3.15$2.9711,071 shs$16.18 million09/23/2024$3.13$3.06-2.24%$3.19$3.053,844 shs$16.62 million09/20/2024$2.92$3.13+7.19%$3.13$2.9322,267 shs$17.00 million625,000% Gain (Ad)Imagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.>> Dive into the Workshop Here09/19/2024$2.86$2.92+2.10%$2.95$2.926,179 shs$15.86 million09/18/2024$3.01$2.86-4.98%$3.07$2.8611,264 shs$15.53 million09/17/2024$3.09$3.01-2.43%$3.20$2.9018,182 shs$16.34 million09/16/2024$3.15$3.09-2.07%$3.26$3.075,780 shs$16.75 million09/13/2024$3.42$3.15-7.89%$3.32$3.0316,974 shs$17.11 million09/12/2024$3.22$3.42+6.21%$3.50$3.1811,258 shs$18.57 million09/11/2024$3.28$3.22-1.83%$3.40$3.1311,600 shs$17.49 million09/10/2024$3.30$3.28-0.61%$3.34$3.105,261 shs$17.81 million09/09/2024$3.35$3.30-1.49%$3.44$3.255,992 shs$17.92 million09/06/2024$3.36$3.35-0.18%$3.40$2.9910,158 shs$18.19 million09/05/2024$3.50$3.36-4.11%$3.37$3.36859 shs$18.22 million09/04/2024$3.33$3.50+5.11%$3.50$3.162,684 shs$19.01 million09/03/2024$3.43$3.33-2.92%$3.36$3.311,912 shs$18.08 million09/02/2024$3.43$3.43+0.03%$3.45$3.321,600 shs$18.63 million08/30/2024$3.33$3.43+3.05%$3.45$3.321,620 shs$18.63 million08/29/2024$3.50$3.33-4.90%$3.54$3.322,486 shs$18.07 million08/28/2024$3.52$3.50-0.47%$3.55$3.482,631 shs$19.01 million08/27/2024$3.55$3.52-0.94%$3.60$3.402,182 shs$19.10 million08/26/2024$3.51$3.55+1.14%$3.69$3.499,591 shs$19.28 million08/23/2024$3.75$3.51-6.40%$3.83$3.518,144 shs$19.06 million08/22/2024$3.86$3.75-2.85%$3.86$3.755,358 shs$20.36 million08/21/2024$3.72$3.86+3.76%$3.86$3.725,856 shs$20.96 million08/20/2024$3.79$3.72-1.72%$3.72$3.49655 shs$20.20 million08/19/2024$3.80$3.79-0.39%$3.80$3.625,340 shs$20.55 million08/16/2024$3.41$3.80+11.44%$3.80$3.216,241 shs$20.63 million08/15/2024$3.25$3.41+4.92%$3.42$3.2110,215 shs$18.52 million08/14/2024$3.30$3.25-1.52%$3.40$3.2011,422 shs$17.65 million Related Companies ANL Stock Chart CUE Stock Chart BYSI Stock Chart CLRB Stock Chart IKNA Stock Chart ALXO Stock Chart CLSD Stock Chart MGX Stock Chart MNOV Stock Chart AVTE Stock Chart Receive APRE Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Aprea Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:APRE) was last updated on 11/15/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredTop "Sleeping Giant" Crypto In The Market NowTop "Sleeping Giant" Crypto In The Market Now We're looking at potential returns that could rewrite your fi...Crypto 101 Media | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredYou just voted for a financial crisisI’d like to share with you my #1 high-conviction stock to buy before Inauguration Day… and details on the asse...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aprea Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Aprea Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free APRE Stock Alerts